- 英文名称
- Everolimus Impurity 4 (Everolimus EP Impurity B)
- 分子式
- C53H83NO14
- 分子量
- 958.22
- 中文别名
- 依维莫司杂质; 依维莫司EP杂质B; 依维莫司杂质4; EP杂质B(依维莫司杂质4); (S)-1-(2-((2R,3R,6S)-2-羟基-6-((2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-羟基-22-((1S,3R,4R)-4-(2-羟基乙氧基)-3-甲氧基环己基)-2,13-二甲氧基-3,9,11,15,17,21-六甲基-12,18-二氧代-3,5,7,15,19-戊烯-1-基)-3-甲基四氢-2H-吡喃-2-基)-2-氧代乙酰基)哌啶-2-羧酸; (19E/Z)-SECO-[4-O-(2-羟乙基)]雷帕霉素; (2S)-1-{[(2R,3R,6S)-2-Hydroxy-6-{(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-hydroxy-22-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaen-1-yl}-3-methyltetrahydro-2H-pyran-2-yl](oxo)acetyl}-2-piperidinecarboxylic acid; Everolimus EP Impurity B; (S)-1-(2-((2R,3R,6S)-2-hydroxy-6-((2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-hydroxy-22-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxodocosa-3,5,7,15,19-pentaen-1-yl)-3-methyltetrahydro-2H-pyran-2-yl)-2-oxoacetyl)piperidine-2-carboxylic acid; Everolimus-19-ene open ring; Everolimus EP Impurity B (Acid); (19E/Z)-seco-[4-O-(2-Hydroxyethyl)]Rapamycin; Everolimus Related Compound 2
- 用途
- 化学合成。
